Ezetimibe, an inhibitor of intestinal cholesterol absorption, decreases serum level of malondialdehyde-modified low-density lipoprotein in patients with hypercholesterolemia

Int J Cardiol. 2011 Feb 3;146(3):420-1. doi: 10.1016/j.ijcard.2010.10.082. Epub 2010 Nov 23.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anticholesteremic Agents / pharmacology*
  • Azetidines / pharmacology*
  • Cholesterol / metabolism
  • Ezetimibe
  • Female
  • Humans
  • Hypercholesterolemia / blood*
  • Hypercholesterolemia / metabolism
  • Intestinal Absorption / drug effects
  • Lipoproteins, LDL / blood*
  • Male
  • Middle Aged

Substances

  • Anticholesteremic Agents
  • Azetidines
  • Lipoproteins, LDL
  • Cholesterol
  • Ezetimibe